West Pharmaceutical Services — 8-K/A confirms full operational restoration, data investigation ongoing

UPDATE (originally covered 2026-W21): West Pharmaceutical Services (NYSE: WST) filed an 8-K/A amendment under SEC Item 1.05 on 2026-05-20 confirming full operational restoration across all manufacturing, supply chain, and commercial sites globally after the May 4 ransomware intrusion (SEC EDGAR 8-K/A, 2026-05-20). No unauthorized activity observed since 2026-05-05. Data exfiltration scope and threat actor attribution remain under investigation; Palo Alto Networks Unit 42 is conducting the forensic response. The 8-K/A marks formal closure of the containment phase under the SEC's mandatory cyber-incident disclosure cycle; data impact scope will require a further disclosure when the investigation concludes.